Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer

NCT02789345

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Villejuif, France
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cheong Ju-City, South Korea
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seongnam, South Korea
View Trial Details
Completed

Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer

NCT01459497

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Georgetown Cancer Center (Austin Cancer Center) Austin, Texas, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • Md Anderson Cancer Center Houston, Texas, United States
  • Baylor Research Institute Dallas, Baylor Irving Irving, Texas, United States
View Trial Details
Completed

Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia

NCT04803305

Conditions
Adnexal Diseases, Anorexia, Body Weight, +57 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • Tower Hematology Oncology Medical Group (THO) Beverly Hills, California, United States
  • Ventura County Hematology- Oncology Specialists Camarillo, California, United States
  • Cedars- Sinai Medical Center Los Angeles, California, United States
View all 33 locations
View Trial Details
Completed

A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer

NCT01763645

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Brest Regional Clinical Dispensary Brest, Belarus
  • Grodno Regional Clinical Hospital Grodno, Belarus
  • Gomel Regional Clinical Oncology Dispensary Homyel, Belarus
  • Vitebsk Regional Clinical Oncology Dispensary Vitebsk, Belarus
View all 44 locations
View Trial Details
Completed

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

NCT03454451

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +78 more
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • City Of Hope Duarte, California, United States
  • UC San Francisco San Francisco, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View all 27 locations
View Trial Details

Related conditions